SBC Medical Group Holdings Incorporated Financials
This page shows SBC Medical Group Holdings Incorporated (SBC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
SBC Medical Group Holdings Incorporated has an operating margin of 42.5%, meaning the company retains $42 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 34.2% the prior year.
SBC Medical Group Holdings Incorporated's revenue declined 22.7% year-over-year, from $205.4M to $158.9M. This contraction results in a growth score of 0/100.
SBC Medical Group Holdings Incorporated carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.78, SBC Medical Group Holdings Incorporated holds $3.78 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 74/100.
SBC Medical Group Holdings Incorporated has a free cash flow margin of 14.6%, earning a moderate score of 62/100. The company generates positive cash flow after capital investments, but with room for improvement.
SBC Medical Group Holdings Incorporated's ROE of 20.5% shows moderate profitability relative to equity, earning a score of 57/100. This is down from 23.9% the prior year.
SBC Medical Group Holdings Incorporated scores 4.77, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
SBC Medical Group Holdings Incorporated passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, SBC Medical Group Holdings Incorporated generates $0.48 in operating cash flow ($24.7M OCF vs $51.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
SBC Medical Group Holdings Incorporated earns $455.3 in operating income for every $1 of interest expense ($67.5M vs $148K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
SBC Medical Group Holdings Incorporated generated $158.9M in revenue in fiscal year 2025. This represents a decrease of 22.7% from the prior year.
SBC Medical Group Holdings Incorporated's EBITDA was $70.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5.3% from the prior year.
SBC Medical Group Holdings Incorporated reported $51.0M in net income in fiscal year 2025. This represents an increase of 9.4% from the prior year.
SBC Medical Group Holdings Incorporated earned $0.50 per diluted share (EPS) in fiscal year 2025. This represents an increase of 4.2% from the prior year.
Cash & Balance Sheet
SBC Medical Group Holdings Incorporated generated $23.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 29.1% from the prior year.
SBC Medical Group Holdings Incorporated held $163.8M in cash against $42.8M in long-term debt as of fiscal year 2025.
SBC Medical Group Holdings Incorporated had 103M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.
Margins & Returns
SBC Medical Group Holdings Incorporated's gross margin was 80.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.1 percentage points from the prior year.
SBC Medical Group Holdings Incorporated's operating margin was 42.5% in fiscal year 2025, reflecting core business profitability. This is up 8.3 percentage points from the prior year.
SBC Medical Group Holdings Incorporated's net profit margin was 32.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.4 percentage points from the prior year.
SBC Medical Group Holdings Incorporated's ROE was 20.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.4 percentage points from the prior year.
Capital Allocation
SBC Medical Group Holdings Incorporated spent $5.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
SBC Medical Group Holdings Incorporated invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 45.4% from the prior year.
SBC Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.4M0.0% | $43.4M-8.4% | $47.3M+6.5% | $44.4M-16.3% | $53.1M0.0% | $53.1M-3.1% | $54.8M | N/A |
| Cost of Revenue | $12.7M-4.5% | $13.3M+39.1% | $9.6M-9.0% | $10.5M+7.1% | $9.8M-28.0% | $13.7M-10.5% | $15.3M | N/A |
| Gross Profit | $30.6M+2.0% | $30.0M-20.5% | $37.7M+11.4% | $33.9M-21.7% | $43.2M+9.7% | $39.4M-0.3% | $39.5M | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $14.7M-4.7% | $15.5M+14.2% | $13.5M-2.5% | $13.9M-16.4% | $16.6M+36.8% | $12.1M-19.5% | $15.1M | N/A |
| Operating Income | $15.9M+9.1% | $14.6M-39.9% | $24.2M+413.0% | $4.7M-65.9% | $13.8M-49.3% | $27.3M+11.6% | $24.5M | N/A |
| Interest Expense | $45K-3.9% | $47K+1078.3% | $4K-68.1% | $12K+126.9% | $5K-26.4% | $7K+146.8% | $3K | N/A |
| Income Tax | $5.7M-48.9% | $11.1M+11.5% | $10.0M+2138.6% | -$489K-104.8% | $10.3M+20.5% | $8.5M+0.9% | $8.5M | N/A |
| Net Income | $12.8M+421.7% | $2.5M-88.6% | $21.5M+228.8% | $6.5M+130.8% | $2.8M-84.7% | $18.5M-1.5% | $18.8M | N/A |
| EPS (Diluted) | $0.12+500.0% | $0.02-90.5% | $0.21 | N/A | $0.03-85.0% | $0.200.0% | $0.20 | N/A |
SBC Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $321.4M+1.9% | $315.3M+10.8% | $284.6M+7.0% | $266.1M-10.3% | $296.5M+1418.4% | $19.5M-1.1% | $19.8M-92.4% | $258.8M |
| Current Assets | $227.2M-5.9% | $241.3M+12.2% | $215.1M+16.6% | $184.5M-8.7% | $202.1M+13895.0% | $1.4M-18.4% | $1.8M-98.9% | $165.9M |
| Cash & Equivalents | $127.4M-16.6% | $152.7M+15.7% | $132.1M+5.6% | $125.0M-9.0% | $137.4M+9821.3% | $1.4M-16.6% | $1.7M-98.4% | $103.0M |
| Inventory | $1.7M-1.6% | $1.7M+0.6% | $1.7M+13.4% | $1.5M-24.7% | $2.0M | N/A | N/A | $3.1M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $4.9M-1.7% | $5.0M+4.8% | $4.8M+3.6% | $4.6M+30.1% | $3.5M | N/A | N/A | $3.6M |
| Total Liabilities | $73.3M+3.8% | $70.6M+21.2% | $58.3M-18.0% | $71.1M-21.9% | $91.0M+968.9% | $8.5M+1.0% | $8.4M-92.7% | $115.0M |
| Current Liabilities | $44.6M-26.5% | $60.7M+25.2% | $48.5M-20.8% | $61.2M-15.5% | $72.4M+1514.9% | $4.5M+1.9% | $4.4M-95.2% | $92.5M |
| Long-Term Debt | $21.1M+197.5% | $7.1M+3.4% | $6.9M+4.0% | $6.6M+701.7% | $823K | N/A | N/A | N/A |
| Total Equity | $248.0M+1.4% | $244.6M+8.0% | $226.4M+16.1% | $195.1M-4.8% | $205.0M+2221.3% | $8.8M-2.1% | $9.0M-93.7% | $142.2M |
| Retained Earnings | $226.2M+6.0% | $213.4M+1.2% | $211.0M+11.3% | $189.5M+3.6% | $182.9M+2873.2% | -$6.6M-4.9% | -$6.3M-104.4% | $142.8M |
SBC Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$20.9M-150.4% | -$8.3M-532.4% | $1.9M+126.4% | -$7.3M-245.7% | $5.0M-73.9% | $19.2M+421.2% | $3.7M-86.8% | $27.9M |
| Capital Expenditures | $43K-86.0% | $307K+20.9% | $254K-57.0% | $590K+44.4% | $409K-52.6% | $863K+22.9% | $702K-88.8% | $6.2M |
| Free Cash Flow | -$20.9M-142.0% | -$8.6M-616.2% | $1.7M+121.2% | -$7.9M-271.5% | $4.6M-74.9% | $18.3M+515.1% | $3.0M-86.3% | $21.7M |
| Investing Cash Flow | -$12.2M-174.2% | $16.4M+1773.1% | -$979K+78.5% | -$4.5M-218.1% | $3.9M+164.1% | -$6.0M-77.1% | -$3.4M+50.6% | -$6.9M |
| Financing Cash Flow | $11.6M+61.1% | $7.2M+2661.6% | -$280K-102.5% | $11.4M-2.7% | $11.7M+17019.0% | -$69K-71.8% | -$40K+68.4% | -$127K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $2.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SBC Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.6%+1.4pp | 69.2%-10.5pp | 79.7%+3.5pp | 76.3%-5.2pp | 81.5%+7.2pp | 74.2%+2.1pp | 72.1% | N/A |
| Operating Margin | 36.6%+3.1pp | 33.6%-17.6pp | 51.1%+40.5pp | 10.6%-15.4pp | 26.1%-25.3pp | 51.4%+6.8pp | 44.6% | N/A |
| Net Margin | 29.6%+23.9pp | 5.7%-39.8pp | 45.4%+30.7pp | 14.7%+9.4pp | 5.3%-29.5pp | 34.8%+0.6pp | 34.2% | N/A |
| Return on Equity | 5.2%+4.2pp | 1.0%-8.5pp | 9.5%+6.2pp | 3.4%+2.0pp | 1.4%-207.9pp | 209.3%+1.3pp | 208.0% | N/A |
| Return on Assets | 4.0%+3.2pp | 0.8%-6.8pp | 7.6%+5.1pp | 2.5%+1.5pp | 1.0%-93.7pp | 94.7%-0.3pp | 95.0% | N/A |
| Current Ratio | 5.10+1.1 | 3.98-0.5 | 4.44+1.4 | 3.01+0.2 | 2.79+2.5 | 0.32-0.1 | 0.40-1.4 | 1.79 |
| Debt-to-Equity | 0.09+0.1 | 0.030.0 | 0.030.0 | 0.03+0.0 | 0.00-1.0 | 0.96+0.0 | 0.93+0.1 | 0.81 |
| FCF Margin | -48.3%-28.3pp | -19.9%-23.5pp | 3.5%+21.3pp | -17.8%-26.4pp | 8.7%-25.9pp | 34.5%+29.1pp | 5.4% | N/A |
Similar Companies
Frequently Asked Questions
What is SBC Medical Group Holdings Incorporated's annual revenue?
SBC Medical Group Holdings Incorporated (SBC) reported $158.9M in total revenue for fiscal year 2025. This represents a -22.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is SBC Medical Group Holdings Incorporated's revenue growing?
SBC Medical Group Holdings Incorporated (SBC) revenue declined by 22.7% year-over-year, from $205.4M to $158.9M in fiscal year 2025.
Is SBC Medical Group Holdings Incorporated profitable?
Yes, SBC Medical Group Holdings Incorporated (SBC) reported a net income of $51.0M in fiscal year 2025, with a net profit margin of 32.1%.
What is SBC Medical Group Holdings Incorporated's EBITDA?
SBC Medical Group Holdings Incorporated (SBC) had EBITDA of $70.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does SBC Medical Group Holdings Incorporated have?
As of fiscal year 2025, SBC Medical Group Holdings Incorporated (SBC) had $163.8M in cash and equivalents against $42.8M in long-term debt.
What is SBC Medical Group Holdings Incorporated's gross margin?
SBC Medical Group Holdings Incorporated (SBC) had a gross margin of 80.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is SBC Medical Group Holdings Incorporated's operating margin?
SBC Medical Group Holdings Incorporated (SBC) had an operating margin of 42.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is SBC Medical Group Holdings Incorporated's net profit margin?
SBC Medical Group Holdings Incorporated (SBC) had a net profit margin of 32.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is SBC Medical Group Holdings Incorporated's return on equity (ROE)?
SBC Medical Group Holdings Incorporated (SBC) has a return on equity of 20.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is SBC Medical Group Holdings Incorporated's free cash flow?
SBC Medical Group Holdings Incorporated (SBC) generated $23.3M in free cash flow during fiscal year 2025. This represents a 29.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is SBC Medical Group Holdings Incorporated's operating cash flow?
SBC Medical Group Holdings Incorporated (SBC) generated $24.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are SBC Medical Group Holdings Incorporated's total assets?
SBC Medical Group Holdings Incorporated (SBC) had $380.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are SBC Medical Group Holdings Incorporated's capital expenditures?
SBC Medical Group Holdings Incorporated (SBC) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is SBC Medical Group Holdings Incorporated's current ratio?
SBC Medical Group Holdings Incorporated (SBC) had a current ratio of 3.78 as of fiscal year 2025, which is generally considered healthy.
What is SBC Medical Group Holdings Incorporated's debt-to-equity ratio?
SBC Medical Group Holdings Incorporated (SBC) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SBC Medical Group Holdings Incorporated's return on assets (ROA)?
SBC Medical Group Holdings Incorporated (SBC) had a return on assets of 13.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is SBC Medical Group Holdings Incorporated's Altman Z-Score?
SBC Medical Group Holdings Incorporated (SBC) has an Altman Z-Score of 4.77, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is SBC Medical Group Holdings Incorporated's Piotroski F-Score?
SBC Medical Group Holdings Incorporated (SBC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are SBC Medical Group Holdings Incorporated's earnings high quality?
SBC Medical Group Holdings Incorporated (SBC) has an earnings quality ratio of 0.48x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can SBC Medical Group Holdings Incorporated cover its interest payments?
SBC Medical Group Holdings Incorporated (SBC) has an interest coverage ratio of 455.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is SBC Medical Group Holdings Incorporated?
SBC Medical Group Holdings Incorporated (SBC) scores 65 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.